An Updated Review of the Biomarkers of Response to Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: Merkel Cell Carcinoma and Immunotherapy

An Updated Review of the Biomarkers of Response to Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: Merkel Cell Carcinoma and Immunotherapy

Merkel cell carcinoma (MCC) is primarily a disease of the elderly Caucasian, with most cases occurring in individuals over 50. Immune checkpoint inhibitors (ICI) treatment has shown promising results in MCC patients. Although ~34% of MCC patients are expected to exhibit at least one of the predictiv...

Full description

Bibliographic Details
Main Authors: Adnan Fojnica, Kenana Ljuca, Saghir Akhtar, Zoran Gatalica, Semir Vranic
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
skin
Merkel cell carcinoma
therapy
immune checkpoint inhibitors
biomarkers
Online Access:https://www.mdpi.com/2072-6694/15/20/5084

Similar Items

Similar Items